Organization
Shanghai Ji Ai Genetics & IVF Institute
5 clinical trials
Clinical trial
A Randomized Control Trial to Compare the Euploid Rate of Blastocyst Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients Undergoing PGT-AStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Randomized Control Trial to Compare the Euploid Rate of Blastocyst Between the PPOS (Progestin-primed Ovarian Stimulation) Protocol and the Gonadotropin-releasing Hormone (GnRH) Antagonist Protocol in Women With PCOS (Polycystic Ovary Syndrome) Undergoing PGT-A (Preimplantation Genetic Testing for Aneuploidy)Status: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Randomized Control Trial to Compare the Live Birth Rate Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Undergoing IVFStatus: Completed, Estimated PCD: 2022-10-10
Clinical trial
Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort StudyStatus: Completed, Estimated PCD: 2022-06-30
Clinical trial
A Randomized Comparison of the Live Birth Rate Between the Progestin-primed Ovarian Stimulation Protocol and the Gonadotrophin Releasing Hormone Antagonist Protocol in Patients Undergoing in Vitro FertilizationStatus: Recruiting, Estimated PCD: 2024-09-01